Therapeutic Breakout Sessions: Genentech (Enspryng) The Guthy-Jackson Charitable Foundation 36:27 3 years ago 477 Скачать Далее
Online Breakout Session: Approved Therapeutics The Guthy-Jackson Charitable Foundation 1:27:47 3 years ago 103 Скачать Далее
Introducing Uplizna - A Therapeutic Breakout Session by Viela Bio and GJCF The Guthy-Jackson Charitable Foundation 43:04 3 years ago 311 Скачать Далее
QB3 Webinar: Aviv Regev, Genentech & Roche. “Cell Atlases as Roadmaps in Health and Disease” QB3TV 45:25 2 years ago 5 060 Скачать Далее
RNA or DNA: Which NGS Test To Use - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 1:59 1 year ago 28 Скачать Далее
What are NTRK Mutations? - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 6:05 1 year ago 47 Скачать Далее
ROS1 Treatment Options: Lorlatinib and Repotrectinib - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 3:26 1 year ago 242 Скачать Далее
Emerging Therapies in ALK+ NSCLC - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 2:11 1 year ago 24 Скачать Далее
BRAF+ Disease: BRAF/MEK Combo in Other Mutations - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 6:30 1 year ago 30 Скачать Далее
ROS1 Treatment Options: Crizotinib and Entrectinib - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 7:07 1 year ago 600 Скачать Далее
ALK+ NSCLC: What Does it Mean? - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 1:57 1 year ago 38 Скачать Далее
Disease Progression on Lorlatinib or Osimertinib - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 3:55 1 year ago 56 Скачать Далее
Does Hormonal Therapy Reduce Response to Treatment? - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 2:38 1 year ago 17 Скачать Далее
Breakout Session: Ask the Docs Open Forum Session 1 - 2022 NMO Patient Day The Guthy-Jackson Charitable Foundation 35:58 1 year ago 87 Скачать Далее
Treatment of HER2+ NSCLC - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 7:20 1 year ago 42 Скачать Далее
Trials in HER2+ NSCLC - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 7:27 1 year ago 25 Скачать Далее
